SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive ...
NEWARK, Del, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The global flow cytometry market is on the cusp of a transformative decade, with significant growth projections highlighting its expanding role in ...
Mass cytometry, with detection by TOF, has been a transformative single-cell technology in immunology, immunophenotyping, oncology and infectious disease studies for a decade. It is in use in over 150 ...
SOUTH SAN FRANCISCO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...
We spoke to Stanford University’s Wendy Fantl and Veronica Gonzalez about their novel use of mass cytometry (CyTOF) to identify never-before-seen cell subtypes in high-grade serous ovarian cancer ...
Industry-Leading CyTOF Technology Recognized at the 18th Annual HUPO World Congress for Delivering Unprecedented Proteomic Insight at Single-Cell Resolution SOUTH SAN FRANCISCO, Calif., Sept. 18, 2019 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results